PKM and glioblastoma: Whether in GBM, where PKM2 contributes to chemoresistance and radiotherapy failure, or in other head and neck malignancies, where it facilitates aerobic glycolysis and immune suppression, these findings have redirected research focus toward the diverse oncogenic functions of PKM2, reinforcing its potential as a therapeutic target.